RiboX Therapeutics Receives FDA RMAT Designation for RXRG001 in Radiation-Induced Xerostomia RiboX Therapeutics, a clinical-stage biotechnology company focused on discovering and developing fully engineered circular RNA (circRNA) therapeutics, announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative…
Dunbar Pharmaceuticals to Showcase Pharmaceutical-Grade Plant-Derived Dronabinol at expopharm 2026 Dunbar Pharmaceuticals, also known as Dunbar Pharma, is set to participate in expopharm 2026, one of Europe’s leading trade fairs for the pharmacy sector, as the company continues to expand…
Teleflex Highlights Advanced Vascular Technologies at CIRSE 2026, Featuring Dynetic™-35 Stent System Teleflex Incorporated, a global provider of medical technologies, is set to showcase a range of innovative solutions at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2026…
Stoke Therapeutics and Biogen Present Long-Term Zorevunersen Data Supporting Potential Disease-Modifying Treatment for Dravet Syndrome Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company focused on restoring protein expression through RNA medicine, and Biogen Inc. (Nasdaq: BIIB) have announced the presentation…
Invivoscribe Begins Commercial Shipments of PrepQuant™ System to Advance High-Sensitivity MRD Testing Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, has announced the start of commercial shipments of its PrepQuant™ System in North America. The…
Thermo Fisher Scientific Launches Multiskan Ease Absorbance Microplate Reader for Routine Laboratory Applications Thermo Fisher Scientific has announced the launch of the Thermo Scientific™ Multiskan™ Ease Absorbance Microplate Reader, a new single-mode absorbance microplate reader designed to support a broad…
Transcat Acquires Southeastern Biomedical Associates for $12.8 Million to Expand Biomedical Calibration Services Transcat, Inc., a provider of accredited calibration services and test and measurement equipment, has announced the acquisition of privately held Southeastern Biomedical Associates Incorporated, a move designed…
Cardio Diagnostics Releases Updated Rural Health Report Focused on Improving Cardiovascular Care and Access Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an artificial intelligence-driven precision cardiovascular medicine company, has released an updated edition of its report examining the state of rural…
Vyome Holdings Reports Second-Quarter 2026 Results and Highlights Progress Across Clinical Pipeline Vyome Holdings, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for immuno-inflammatory and rare diseases, has announced its financial results for the second quarter ended June 30,…
AN2 Therapeutics Appoints Cameron Trenor, M.D., as Chief Medical Officer to Advance Clinical Development Pipeline AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel small molecule therapeutics through its proprietary boron chemistry platform, has announced the appointment of…
Charles River Laboratories and Medigen Vaccine Biologics Collaborate to Advance Next-Generation Multivalent Enterovirus Vaccine Charles River Laboratories and Medigen Vaccine Biologics Corp. (MVC) have entered into a strategic collaboration focused on the characterization and validation of the virus seed bank…
Tolerance Bio Licenses Efineptakin Alfa From NeoImmuneTech to Advance Thymus-Targeted Therapies Tolerance Bio, Inc., a biotechnology company focused on preserving, regenerating, and modulating thymic function to address immune-related diseases and potentially extend healthspan, has entered into an exclusive license agreement…